期刊文献+

分析氯吡格雷与质子泵抑制剂的相互作用 被引量:2

原文传递
导出
摘要 目的总结氯吡格雷与质子泵抑制剂的相互作用。方法分析并总结相关研究文献,对氯吡格雷与质子泵抑制剂的相互作用进行阐述。结果与结论氯吡格雷联合阿司匹林能强化抗血小板作用,降低心血管事件发生率,是目前冠状动脉介入术(PCI)后标准的抗血小板治疗方案[1]。但双联抗血小板治疗常引起胃肠道不适,甚至可能增加出血风险。临床常通过合用质子泵抑制剂来预防上消化道出血的发生。近年来,关于质子泵抑制剂对抗血小板治疗的拮抗作用,以及这种拮抗作用能否明显增加PCI后不良心血管事件的发生,成为心血管医师研究的热点。
作者 王平
出处 《首都医药》 2013年第14期27-28,共2页 Capital Medicine
  • 相关文献

参考文献15

  • 1蔡军,武强,孙静,龙梅,刘长福.不同质子泵抑制剂对PCI术后氯吡格雷抗血小板临床效果的影响[J].解放军医学杂志,2010,35(12):1481-1483. 被引量:19
  • 2Siller M atula JM, Jilma B, Schror K, et al. Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogre:insystem atic review and meta-analysis[J].J Thromb Haemos t, 2010, 8 (12) : 2624 - 2641.
  • 3Kim effect on th pharma Kh, Park PW, Hong SJ, et al.The of CYP2C19 polymorph ism e pharmacia inetics and codynamics possible mechanism resistance[J].C1 of clopidogre:la for clop idogrel in Pharmacol Ther, 2008, 84 (2): 236- 242.
  • 4Venerito M, Kandulski A, Malfertheiner P. Dilemma between gastroprotection and cardiovascular prevention[J] Dtsch Med Wochenschr, 2010,135(44) 2193 - 2198.
  • 5白鹏,周丽雅.抗血小板药物所致消化道损伤及其防护研究进展[J].中国实用内科杂志,2011,31(8):654-656. 被引量:8
  • 6ShiS, K lotz U. Proton pump inhibitors:an update of their clinical use and pharmacia inetics[J].Eur J Clin Pharmaco, 2008, 64 (10): 935- 951.
  • 7RayWA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clop idogrel and proton pump inhibitors:a cohort study[J]. AnnIntern Med, 2010,152(6):337-345.
  • 8Yasuda H, Yam al. Upper gaston ada M, Sawada S, et test in a bleeding in patients r antiplatelet thera stenting[J]. Intern 1725-1730 eceiving dual py after coronary Med, 2009, 48 (19) :.
  • 9Garrido A, Iborra M I, Saperas E, et al. Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors[J].Med Clin (Barc), 2010, 134 (13): 577- 582.
  • 10Cryer B. Management with high gastro intest antiplate let therapy[J]. Clin North Am, 2009,38(2): of ptients inal risk on Gastroenterol 289- 303.

二级参考文献50

  • 1韩雅玲,王耿,荆全民,王守力,王祖禄,王冬梅,马颖艳,栾波.急性冠状动脉综合征介入治疗4670例近期疗效的评价[J].中华医学杂志,2005,85(15):1040-1044. 被引量:47
  • 2De.rry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis[J]. BMJ, 2000, 321(7270):1183-1187.
  • 3Juurlink DN, Comes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel [J]. CMAJ, 2009, 180(7): 713-718.
  • 4Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes as sociated with concomitant use of clopidogrel and proton pump inhibi tors following acute coronary syndrome[J]. JAMA, 2009, 301(9):937-944.
  • 5Sibbing D, Morath T, Stegherr J, et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogre[J]. Thromb Haem ost, 2009, 101(4): 714-719.
  • 6Calderon Hernanz B, Pinteno Blanco M, Puigventos Latorre F, et al. Safety and effectiveness of combining clopidogrel and proton pump inhibitors[J].Farm Hosp, 2009, 33(6): 338-339.
  • 7Yasuda H, Yamada M, Sawada S, et al. Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting[J]. Intern Med, 2009, 48(19): 1725-1730.
  • 8Savi P, Pereillo JM, Uzabiaga MF, et al. Identification and biological activity of the activc metabolite of clopidogrd[J]. Thromb Hacmost, 2000, 84(5): 891-896.
  • 9Anderson JL, Adams CD, Anman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction [J]. J Am Coll Cardiol,2007,50(7) :e1-e157.
  • 10Bhatt DL, Topol EJ. Clopidogrel added to aspirin versus aspirin alone in sec- ondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Manage- ment, and Avoidance (CHARISMA) trial [ J ]. Am Heart J, 2004,148 : 263- 268.

共引文献32

同被引文献35

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部